Ad
related to: biogen nasdaq
Search results
Ionis, Biogen Down on Ending Development of ALS Drug - Biogen (NASDAQ:BIIB), Heron Therapeutics (...
Benzinga· 4 days agoShares of Ionis Pharmaceuticals (NASDAQ: IONS) and Biogen (NASDAQ: BIIB) lost at least 2% in market...
Biogen and Ionis Announce Topline Phase 1/2 Study Results of Investigational Drug in Amyotrophic...
Morningstar· 5 days agoBiogen Inc. (Nasdaq: BIIB) and Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) announced the decision to terminate development of BIIB105 ...
Biogen and Ionis halt ALS drug development after trial setback By Investing.com
Investing.com· 5 days agoBiogen Inc. (NASDAQ:BIIB) and Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) have announced the...
Press Releases
Morning Times· 5 days ago(Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachusetts, CEO: Christopher A. Viehbacher ...
...Subcutaneous Maintenance Dosing for the Treatment of Early Alzheimer's Disease Under the Fast...
Benzinga· 7 days agoTOKYO and CAMBRIDGE, Mass., May 14, 2024 /PRNewswire/ -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and Biogen Inc. (NASDAQ:BIIB, Corporate headquarters: Cambridge, Massachusetts, CEO:
Wall Street Favorites: 3 Biotech Stocks with Strong Buy Ratings for May 2024
InvestorPlace· 4 days agoAll on excitement for its injectable and oral treatments for weight loss, both of which are still in...
Top Stock Movers Now: Walmart, Canada Goose, Deere, and More
Investopedia· 5 days agoThe Dow, S&P 500, and Nasdaq rose to fresh highs intraday Thursday, with the Dow crossing the 40,000...
Eisai projects Leqembi® revenue to total JPY 56.5 billion for fiscal year 2024 (April 2024 - March...
FOX 23 News Albany· 6 days agoBioArctic AB's (publ) (NASDAQ STOCKHOLM: BIOA B) partner Eisai today said that they expect Leqembi...
The Zacks Analyst Blog Highlights Novavax, Sanofi, Fulcrum Therapeutics, Moderna and Bristol Myers
Zacks via Yahoo Finance· 4 days agoPerformance The Nasdaq Biotechnology Index has moved up 2.32% in the past five trading sessions and ...